Correlation Between Pacific Biosciences and Stryker

Can any of the company-specific risk be diversified away by investing in both Pacific Biosciences and Stryker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacific Biosciences and Stryker into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pacific Biosciences of and Stryker, you can compare the effects of market volatilities on Pacific Biosciences and Stryker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacific Biosciences with a short position of Stryker. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacific Biosciences and Stryker.

Diversification Opportunities for Pacific Biosciences and Stryker

0.17

Correlation Coefficient

Pacific Biosciences  Stryker

Average diversification

The 3 months correlation between Pacific and Stryker is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Pacific Biosciences of and Stryker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stryker and Pacific Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacific Biosciences of are associated (or correlated) with Stryker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stryker has no effect on the direction of Pacific Biosciences i.e., Pacific Biosciences and Stryker go up and down completely randomly.

Pair Corralation between Pacific Biosciences and Stryker

Given the investment horizon of 90 days Pacific Biosciences of is expected to generate 5.75 times more return on investment than Stryker. However, Pacific Biosciences is 5.75 times more volatile than Stryker. It trades about 0.06 of its potential returns per unit of risk. Stryker is currently generating about 0.0 per unit of risk. If you would invest  174.00  in Pacific Biosciences of on September 23, 2024 and sell it today you would earn a total of  23.00  from holding Pacific Biosciences of or generate 13.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pacific Biosciences of  vs.  Stryker

Pacific Biosciences

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pacific Biosciences of are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Pacific Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Stryker

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stryker has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Stryker is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Pacific Biosciences and Stryker

The main advantage of trading using opposite Pacific Biosciences and Stryker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacific Biosciences position performs unexpectedly, Stryker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stryker will offset losses from the drop in Stryker's long position.

The idea behind Pacific Biosciences of and Stryker pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.